Connor, Clark & Lunn Investment Management (CC&L)
BCLI

Connor, Clark & Lunn Investment Management (CC&L)’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BCLI Stock Details BCLI Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-791
Closed -$24.4K – 1366
2023
Q2 		$24.4K Buy
+791
New +$24.4K ﹤0.01% 1282